MONTREAL, QUEBEC -- (MARKET WIRE) -- May 31, 2007 -- ZOOMMED inc. (TSX VENTURE: ZMD). In accordance with its marketing strategy, ZoomMed is proud to announce the conclusion of a new agreement, for a total annual amount of $160,000 with two major pharmaceutical corporations; BRISTOL-MYERS SQUIBB and SANOFI AVENTIS, regarding guaranteed purchases of product placement as well as rapid and massive broadcast of information aimed at physicians via the “ZRx Prescriber”.
